Login / Signup

Oral Deliverable Mucoadhesive Chitosan-Salmonella Subunit Nanovaccine for Layer Chickens.

Vilwanathan RavikumarAshley D MarkaziSantosh DhakalYashavanth S LakshmanappaRevathi ShanmugasundaramRamesh K SelvarajGourapura J Renukaradhya
Published in: International journal of nanomedicine (2020)
Our study demonstrated that the chitosan-based oral Salmonella nanovaccine targets immune cells of chickens and induced antigen-specific B and T cell responses. This candidate oral Salmonella nanovaccine has the potential to mitigate Salmonellosis in poultry.
Keyphrases
  • escherichia coli
  • listeria monocytogenes
  • drug delivery
  • heat stress
  • high glucose
  • diabetic rats
  • drug induced
  • climate change